Fenwick & West has advised Lycia Therapeutics. Lycia Therapeutics, a clinical-stage biotechnology company, has completed a $75 million Series D financing round. The funding round was...
Lycia Therapeutics Secures $75 Million in Series D Financing
Turnout Secures $35 Million Series A to Expand AI Advocacy Services
Fenwick & West has advised Turnout on the transaction. Turnout, an AI-powered consumer advocacy service, has raised $35 million in its Series A funding round, bringing...
Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction
Baker McKenzie has advised Servier, and Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One on IP matters related...
CorMedix Acquires Melinta Therapeutics in $300 Million Deal
Fenwick & West LLP has advised Melinta Therapeutics on the transaction, and Katten Muchin Rosenman LLP has advised Deerfield Management Company, L.P. Melinta Therapeutics, a commercial-stage...
Figma Announces $1.2 Billion Initial Public Offering
Fenwick has advised Figma on the offering, Latham & Watkins has advised the underwriters. Whalen LLP has acted as counsel for the selling stockholders. Figma, a...
GeneDX’s Acquisition of Fabric Genomics
Fenwick & West represented GeneDX in the transaction, and DLA Piper advised Fabric Genomics, Inc. GeneDX (Nasdaq: WGS), a company delivering improved health outcomes through genomic...
Synapticure’s $25 Million Series A Funding Round
Fenwick & West represented Synapticure in the transaction. Synapticure, a virtual care company announced raising $25 million in Series A financing round led by B Capital,...
Hebbia’s $130 Million Series B Funding Round
Fenwick & West represented Hebbia in the transaction. Hebbia, a generative AI platform used to search large documents and return answers, announced it has raised $130...
Med-Metrix’s Acquisition of HBCS
Fenwick & West represented Hospital Billing & Collection Service, Ltd in the transaction. Hospital Billing & Collection Service, Ltd (“HBCS”), a tech-enabled RCM company that offers...
Incyte’s $750 Million Acquisition of Escient Pharmaceuticals
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...